Clinical Trial Update: Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety and immunogenicity of an inactivated West Nile virus vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• West Nile Virus Infection

Drugs mentioned

• Inactivated West Nile virus vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: West Nile Viral Infection | Phase 1 | Status: ACTIVE_NOT_RECRUITING